Literature DB >> 26922887

Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.

F Lacombe1, E Bernal2, D Bloxham3, S Couzens4, M G D Porta5, U Johansson6, W Kern7, M Macey8, T Matthes9, R Morilla10, A Paiva11, C Palacio12, F Preijers13, R Ratei14, S Siitonen15, K Allou1, A Porwit16, M C Béné17.   

Abstract

Mesh：

Year:  2016        PMID： 26922887     DOI： 10.1038/leu.2016.44

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study.

Authors:  Françoise Solly; Lauren Rigollet; Lucille Baseggio; Julien Guy; Jessica Borgeot; Estelle Guérin; Agathe Debliquis; Bernard Drenou; Lydia Campos; Francis Lacombe; Marie C Béné
Journal:  Cytometry A       Date:  2013-10-21       Impact factor: 4.355

Review 2.  Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

Authors:  M C Béné; T Nebe; P Bettelheim; B Buldini; H Bumbea; W Kern; F Lacombe; P Lemez; I Marinov; E Matutes; M Maynadié; U Oelschlagel; A Orfao; R Schabath; M Solenthaler; G Tschurtschenthaler; A M Vladareanu; G Zini; G C Faure; A Porwit
Journal:  Leukemia       Date:  2011-01-21       Impact factor: 11.528

3.  Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy.

Authors:  Stéphanie Mathis; Nicolas Chapuis; Jessica Borgeot; Marc Maynadié; Michaela Fontenay; Marie-Christine Béné; Julien Guy; Valérie Bardet
Journal:  Cytometry B Clin Cytom       Date:  2014-11-17       Impact factor: 3.058

4.  Establishment of harmonization in immunophenotyping: A comparative study of a standardized one-tube lymphocyte-screening panel.

Authors:  F W M B Preijers; E Huys; C Favre; B Moshaver
Journal:  Cytometry B Clin Cytom       Date:  2014-11       Impact factor: 3.058

Review 5.  Flow cytometric immunophenotyping for hematologic neoplasms.

Authors:  Fiona E Craig; Kenneth A Foon
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

6.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

Review 7.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.

Authors:  T Kalina; J Flores-Montero; V H J van der Velden; M Martin-Ayuso; S Böttcher; M Ritgen; J Almeida; L Lhermitte; V Asnafi; A Mendonça; R de Tute; M Cullen; L Sedek; M B Vidriales; J J Pérez; J G te Marvelde; E Mejstrikova; O Hrusak; T Szczepański; J J M van Dongen; A Orfao
Journal:  Leukemia       Date:  2012-09       Impact factor: 11.528
  7 in total
  12 in total

1.  2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.

Authors:  Michael Heuser; Sylvie D Freeman; Gert J Ossenkoppele; Francesco Buccisano; Christopher S Hourigan; Lok Lam Ngai; Jesse M Tettero; Costa Bachas; Constance Baer; Marie-Christine Béné; Veit Bücklein; Anna Czyz; Barbara Denys; Richard Dillon; Michaela Feuring-Buske; Monica L Guzman; Torsten Haferlach; Lina Han; Julia K Herzig; Jeffrey L Jorgensen; Wolfgang Kern; Marina Y Konopleva; Francis Lacombe; Marta Libura; Agata Majchrzak; Luca Maurillo; Yishai Ofran; Jan Philippe; Adriana Plesa; Claude Preudhomme; Farhad Ravandi; Christophe Roumier; Marion Subklewe; Felicitas Thol; Arjan A van de Loosdrecht; Bert A van der Reijden; Adriano Venditti; Agnieszka Wierzbowska; Peter J M Valk; Brent L Wood; Roland B Walter; Christian Thiede; Konstanze Döhner; Gail J Roboz; Jacqueline Cloos
Journal:  Blood       Date:  2021-12-30       Impact factor: 22.113

Review 2.  Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.

Authors:  Matteo G Della Porta; Cristina Picone
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-15       Impact factor: 2.576

3.  Innovation in Flow Cytometry Analysis: A New Paradigm Delineating Normal or Diseased Bone Marrow Subsets Through Machine Learning.

Authors:  Francis Lacombe; Benoît Dupont; Nicolas Lechevalier; Jean Philippe Vial; Marie C Béné
Journal:  Hemasphere       Date:  2019-02-22

Review 4.  Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies.

Authors:  Barbara Buldini; Margarita Maurer-Granofszky; Elena Varotto; Michael N Dworzak
Journal:  Front Pediatr       Date:  2019-10-11       Impact factor: 3.418

5.  Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia.

Authors:  Jean Philippe Vial; Nicolas Lechevalier; Francis Lacombe; Pierre-Yves Dumas; Audrey Bidet; Thibaut Leguay; François Vergez; Arnaud Pigneux; Marie C Béné
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

6.  AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML.

Authors:  Diana Hanekamp; Jesse M Tettero; Gert J Ossenkoppele; Angèle Kelder; Jacqueline Cloos; Gerrit Jan Schuurhuis
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 7.  Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Authors:  Gerrit J Schuurhuis; Michael Heuser; Sylvie Freeman; Marie-Christine Béné; Francesco Buccisano; Jacqueline Cloos; David Grimwade; Torsten Haferlach; Robert K Hills; Christopher S Hourigan; Jeffrey L Jorgensen; Wolfgang Kern; Francis Lacombe; Luca Maurillo; Claude Preudhomme; Bert A van der Reijden; Christian Thiede; Adriano Venditti; Paresh Vyas; Brent L Wood; Roland B Walter; Konstanze Döhner; Gail J Roboz; Gert J Ossenkoppele
Journal:  Blood       Date:  2018-01-12       Impact factor: 25.476

8.  Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting.

Authors:  Diana Hanekamp; Alexander N Snel; Angèle Kelder; Willemijn J Scholten; Naeem Khan; Marlen Metzner; Maria Irno-Consalvo; Mayumi Sugita; Anja de Jong; Sjoerd Oude Alink; Harrie Eidhof; Miriam Wilhelm; Michaela Feuring-Buske; Jennichjen Slomp; Vincent H J van der Velden; Edwin Sonneveld; Monica Guzman; Gail J Roboz; Francesco Buccisano; Paresh Vyas; Sylvie Freeman; Costa Bachas; Gert J Ossenkoppele; Gerrit J Schuurhuis; Jacqueline Cloos
Journal:  Br J Haematol       Date:  2020-04-02       Impact factor: 6.998

9.  Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.

Authors:  Monali Gupta; Katayoon Jafari; Amr Rajab; Cuihong Wei; Joanna Mazur; Anne Tierens; Elizabeth Hyjek; Rumina Musani; Anna Porwit
Journal:  Cytometry B Clin Cytom       Date:  2020-12-10       Impact factor: 3.058

10.  [Chinese consensus on minimal residual disease detection and interpretation of patients with acute myeloid leukemia (2021)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.